donepezil has been researched along with Cortical Lewy Body Disease in 69 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined attention-enhancing effects of the cholinesterase inhibitor donepezil in Dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) by means of open label study." | 9.12 | Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. ( Burn, D; Daniel, S; McKeith, IG; Mosimann, U; Newby, J; O'Brien, JT; Rowan, E; Sanders, J; Saxby, BK; Wesnes, K, 2007) |
| "This open label study was designed to assess the effects of donepezil treatment, its withdrawal and subsequent recommencement on cognitive functioning, behaviour and parkinsonian symptoms in patients with probable dementia with Lewy bodies (DLB) and with Parkinson's disease who subsequently developed dementia (PDD)." | 9.10 | What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. ( Daniel, SL; Littlewood, E; McKeith, IG; Minett, TS; Myint, P; Newby, J; Richardson, J; Sanders, J; Thomas, A; Wilkinson, LM, 2003) |
| " We enrolled 24 patients with DLB (diagnosed according to the Consortium on Dementia with Lewy Bodies Guideline-Revised) who experienced a relapse of BPSD despite treatment with donepezil at the standard dose (5 mg/day)." | 7.83 | Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies. ( Ino, T; Kosaka, K; Manabe, Y; Yamanaka, K, 2016) |
| "We reported a patient with probable dementia with Lewy bodies (DLB) showing cervical dystonia during treatment with donepezil." | 7.76 | [Case of dementia with Lewy bodies showing cervical dystonia after donepezil administration]. ( Hasegawa, N; Maeda, K; Shimada, K; Yamamoto, Y, 2010) |
| "She was diagnosed as having parkinsonism and took medication." | 5.32 | [A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: a case report]. ( Kondo, T; Miwa, H; Morita, S, 2004) |
| "We examined attention-enhancing effects of the cholinesterase inhibitor donepezil in Dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) by means of open label study." | 5.12 | Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. ( Burn, D; Daniel, S; McKeith, IG; Mosimann, U; Newby, J; O'Brien, JT; Rowan, E; Sanders, J; Saxby, BK; Wesnes, K, 2007) |
| "This open label study was designed to assess the effects of donepezil treatment, its withdrawal and subsequent recommencement on cognitive functioning, behaviour and parkinsonian symptoms in patients with probable dementia with Lewy bodies (DLB) and with Parkinson's disease who subsequently developed dementia (PDD)." | 5.10 | What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. ( Daniel, SL; Littlewood, E; McKeith, IG; Minett, TS; Myint, P; Newby, J; Richardson, J; Sanders, J; Thomas, A; Wilkinson, LM, 2003) |
| "Some randomized studies, mostly of short duration, have indicated that cholinesterase inhibitors (donepezil, rivastigmine and galantamine) may have a beneficial effect in Alzheimer's disease, vascular dementia and in dementia caused by Lewy body disease." | 4.84 | [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]. ( Landmark, K; Reikvam, A, 2008) |
| " We enrolled 24 patients with DLB (diagnosed according to the Consortium on Dementia with Lewy Bodies Guideline-Revised) who experienced a relapse of BPSD despite treatment with donepezil at the standard dose (5 mg/day)." | 3.83 | Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies. ( Ino, T; Kosaka, K; Manabe, Y; Yamanaka, K, 2016) |
| "We reported a patient with probable dementia with Lewy bodies (DLB) showing cervical dystonia during treatment with donepezil." | 3.76 | [Case of dementia with Lewy bodies showing cervical dystonia after donepezil administration]. ( Hasegawa, N; Maeda, K; Shimada, K; Yamamoto, Y, 2010) |
| "In this retrospective analysis, AD patients who had symptoms suggestive of concomitant Lewy body disease appeared to show greater treatment responses to rivastigmine than to donepezil, and experienced fewer adverse events under either drug, compared with patients without Lewy body pathology." | 3.73 | Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology. ( Bergman, H; Bullock, R; Lane, R; Nagel, J; Rapatz, G; Touchon, J, 2006) |
| " There was no significant imbalance in the incidence of adverse events (AEs) by onset time, and delayed AE onset induced by the long-term administration of donepezil was unlikely to appear." | 2.78 | Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. ( Hashimoto, M; Ikeda, M; Iseki, E; Kosaka, K; Matsukawa, N; Matsuo, K; Mori, E; Nakagawa, M, 2013) |
| "Donepezil treatment may modify regional glucose metabolism." | 2.75 | Improved visual hallucination by donepezil and occipital glucose metabolism in dementia with Lewy bodies: the Osaki-Tajiri project. ( Ishii, H; Ishikawa, H; Kasuya, M; Meguro, K; Satoh, M; Yamaguchi, S, 2010) |
| " An unexpectedly large placebo effect, inadequate dosage (mean 120 mg/day), and inadequate power may have contributed to lack of demonstrable benefit." | 2.73 | Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. ( Cummings, J; Kurlan, R; Raman, R; Thal, L, 2007) |
| " Donepezil is expected to be therapeutically useful and safe in treating DLB patients, indicating marked improvements in behavioral and psychological symptoms of dementia (BPSD) rather than in cognitive deficit, without deteriorating parkinsonism." | 2.72 | Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. ( Iseki, E; Kosaka, K; Mori, E; Mori, S, 2006) |
| "Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) are the two most common types of dementing neurodegenerative disease after Alzheimer's disease (AD)." | 2.46 | Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. ( Deuschl, G; Förstl, H; Mollenhauer, B; Oertel, W; Storch, A; Trenkwalder, C, 2010) |
| "Studies on Alzheimer's disease and Lewy body dementias show that cholinesterase inhibitors are still first line treatment for these diseases and memantine is indicated in moderate/severe Alzheimer's disease, whereas there is as yet no standard available treatment for frontotemporal dementias." | 2.44 | Reports in pharmacological treatments in geriatric psychiatry: is there anything new or just adding to old evidence? ( Engelhardt, E; Laks, J, 2008) |
| "Donepezil was well tolerated, but haloperidol administration was followed by development of severe dystonia." | 1.43 | DatSCAN In Differential Diagnostics of Lewy Body Disease. ( Ivanova, K; Luzny, J, 2016) |
| "Lewy body disease is a common cause of dementia." | 1.33 | Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia. ( Alwahhabi, FK, 2005) |
| "Fluctuations in consciousness and visual hallucinations are common neuropsychiatric features of dementia with Lewy bodies and Parkinson's disease dementia." | 1.33 | Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. ( Burn, DJ; Firbank, MJ; McKeith, IG; Mosimann, UP; O'Brien, JT, 2005) |
| "Delayed disease progression and symptomatic improvement occur with cholinesterase inhibitors (ChEIs) in dementia with Lewy bodies (DLB)." | 1.33 | Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies. ( Bhanji, NH; Gauthier, S, 2005) |
| "Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits." | 1.32 | A case study in the treatment of dementia with Lewy bodies. ( Kaufer, DI, 2004) |
| "She was diagnosed as having parkinsonism and took medication." | 1.32 | [A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: a case report]. ( Kondo, T; Miwa, H; Morita, S, 2004) |
| "Donepezil therapy was discontinued prematurely in three of the cases due to insufficient response and/or adverse events." | 1.31 | Donepezil for behavioural disorders associated with Lewy bodies: a case series. ( Herrmann, N; Lanctôt, KL, 2000) |
| "Bromperidol 12 mg was prescribed to treat his symptoms." | 1.31 | [Malignant syndrome caused by a combination of bromperidol and donepezil hydrochloride in a patient with probable dementia with Lewy bodies]. ( Iwado, H; Morita, Y; Shinjo, H; Ueki, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 43 (62.32) | 29.6817 |
| 2010's | 26 (37.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, M | 8 |
| Mori, E | 7 |
| Kosaka, K | 11 |
| Iseki, E | 5 |
| Hashimoto, M | 2 |
| Matsukawa, N | 1 |
| Matsuo, K | 2 |
| Nakagawa, M | 6 |
| Leikin, JB | 1 |
| Braund, V | 1 |
| DesLauris, C | 1 |
| Shoji, M | 1 |
| Tagawa, R | 1 |
| Hashimoto, H | 1 |
| Nakanishi, A | 1 |
| Kawarada, Y | 1 |
| Muramatsu, T | 1 |
| Matsuda, Y | 1 |
| Kataoka, K | 1 |
| Shimada, A | 1 |
| Uchida, K | 1 |
| Yoshida, A | 1 |
| Higashiyama, S | 1 |
| Kawabe, J | 1 |
| Kai, T | 2 |
| Shiomi, S | 1 |
| Mori, H | 1 |
| Inoue, K | 1 |
| Manabe, Y | 1 |
| Ino, T | 1 |
| Yamanaka, K | 1 |
| Miyagishi, H | 4 |
| Yamaguchi, H | 1 |
| Szigeti, K | 1 |
| Hafeez, MU | 1 |
| Katayama, S | 1 |
| Higashi, Y | 1 |
| Cummings, J | 2 |
| Lai, TJ | 1 |
| Hemrungrojn, S | 1 |
| Mohandas, E | 1 |
| Yun Kim, S | 1 |
| Nair, G | 1 |
| Dash, A | 1 |
| Nakai, K | 1 |
| Luzny, J | 1 |
| Ivanova, K | 1 |
| Kazui, H | 1 |
| Adachi, H | 1 |
| Kanemoto, H | 1 |
| Yoshiyama, K | 1 |
| Wada, T | 1 |
| Tokumasu Nomura, K | 1 |
| Tanaka, T | 1 |
| Josif, S | 1 |
| Graham, K | 1 |
| Laks, J | 1 |
| Engelhardt, E | 1 |
| Kurota, S | 1 |
| Hasegawa, N | 1 |
| Shimada, K | 1 |
| Yamamoto, Y | 1 |
| Maeda, K | 2 |
| Fujita, Y | 1 |
| Takebayashi, M | 1 |
| Kinoshita, T | 1 |
| Hanabusa, H | 1 |
| Mollenhauer, B | 1 |
| Förstl, H | 1 |
| Deuschl, G | 1 |
| Storch, A | 1 |
| Oertel, W | 1 |
| Trenkwalder, C | 1 |
| Satoh, M | 1 |
| Ishikawa, H | 1 |
| Meguro, K | 1 |
| Kasuya, M | 1 |
| Ishii, H | 1 |
| Yamaguchi, S | 1 |
| Ukai, K | 1 |
| Nakamura, R | 1 |
| Sobue, G | 1 |
| Shibayama, H | 1 |
| Iritani, S | 1 |
| Ishihara, R | 1 |
| Ozaki, N | 1 |
| Landau, R | 1 |
| Shinfuku, M | 1 |
| Nakajima, S | 1 |
| Uchida, H | 1 |
| Watanabe, K | 1 |
| Kocha, H | 1 |
| Kashima, H | 1 |
| Rolinski, M | 1 |
| Fox, C | 1 |
| Maidment, I | 1 |
| McShane, R | 1 |
| Lindberg, OM | 1 |
| Hayashi, H | 1 |
| Kawakatsu, S | 1 |
| Suzuki, A | 1 |
| Shibuya, Y | 1 |
| Kobayashi, R | 1 |
| Sato, C | 1 |
| Otani, K | 1 |
| Ozaki, A | 1 |
| Nishida, M | 1 |
| Koyama, K | 1 |
| Ishikawa, K | 1 |
| Nishikawa, T | 1 |
| Minett, TS | 1 |
| Thomas, A | 3 |
| Wilkinson, LM | 1 |
| Daniel, SL | 1 |
| Sanders, J | 3 |
| Richardson, J | 2 |
| Littlewood, E | 2 |
| Myint, P | 1 |
| Newby, J | 3 |
| McKeith, IG | 6 |
| Onofrj, M | 1 |
| Kaufer, DI | 2 |
| Terao, T | 2 |
| Shimomura, T | 1 |
| Izumi, Y | 1 |
| Nakamura, J | 1 |
| Matsumoto, T | 1 |
| Kawanishi, C | 1 |
| Isojima, D | 1 |
| Kishida, I | 1 |
| Massironi, G | 1 |
| Galluzzi, S | 1 |
| Frisoni, GB | 1 |
| Rozzini, L | 1 |
| Ghianda, D | 1 |
| Trabucchi, M | 1 |
| Padovani, A | 1 |
| Morita, S | 1 |
| Miwa, H | 1 |
| Kondo, T | 1 |
| Simard, M | 1 |
| van Reekum, R | 1 |
| Alwahhabi, FK | 1 |
| O'Brien, JT | 4 |
| Firbank, MJ | 1 |
| Mosimann, UP | 2 |
| Burn, DJ | 3 |
| Asai, Y | 1 |
| Sakuma, K | 1 |
| Koeda, T | 1 |
| Nakashima, K | 1 |
| Thomas, AJ | 1 |
| Rowan, EN | 1 |
| Cousins, D | 1 |
| Pakrasi, S | 2 |
| Bhanji, NH | 1 |
| Gauthier, S | 1 |
| Touchon, J | 1 |
| Bergman, H | 1 |
| Bullock, R | 1 |
| Rapatz, G | 1 |
| Nagel, J | 1 |
| Lane, R | 1 |
| Mori, T | 1 |
| Fukuhara, R | 1 |
| Nestor, PJ | 1 |
| Tanabe, H | 1 |
| Mori, S | 1 |
| Ringman, JM | 1 |
| Cummings, JL | 1 |
| Cousins, DA | 1 |
| Lett, D | 1 |
| Johannsen, P | 1 |
| Rowan, E | 2 |
| Saxby, BK | 1 |
| Burn, D | 1 |
| Mosimann, U | 1 |
| Daniel, S | 1 |
| Wesnes, K | 1 |
| Bhasin, M | 1 |
| Edwards, K | 1 |
| McKeith, I | 1 |
| Kurlan, R | 1 |
| Raman, R | 1 |
| Thal, L | 1 |
| Omerovic, M | 1 |
| Teipel, SJ | 1 |
| Hampel, T | 1 |
| Ballard, CG | 1 |
| Chalmers, KA | 1 |
| Todd, C | 1 |
| Wilcock, G | 1 |
| Love, S | 1 |
| Perry, EK | 1 |
| Anghelescu, I | 1 |
| Heuser, I | 1 |
| Landmark, K | 1 |
| Reikvam, A | 1 |
| Fergusson, E | 1 |
| Howard, R | 1 |
| Lanctôt, KL | 1 |
| Herrmann, N | 1 |
| Collinson, S | 1 |
| Samuel, W | 1 |
| Caligiuri, M | 1 |
| Galasko, D | 1 |
| Lacro, J | 1 |
| Marini, M | 1 |
| McClure, FS | 1 |
| Warren, K | 1 |
| Jeste, DV | 1 |
| Skjerve, A | 1 |
| Nygaard, HA | 1 |
| Rojas-Fernandez, CH | 1 |
| Ueki, A | 1 |
| Iwado, H | 1 |
| Shinjo, H | 1 |
| Morita, Y | 1 |
| Arahata, H | 1 |
| Ohyagi, Y | 1 |
| Matsumoto, S | 1 |
| Furuya, H | 1 |
| Murai, H | 1 |
| Kuwabara, Y | 1 |
| Yamada, T | 1 |
| Kira, J | 1 |
| Coulson, BS | 1 |
| Fenner, SG | 1 |
| Almeida, OP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multi-targets, Single-lead GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment[NCT04571112] | 6 participants (Actual) | Interventional | 2017-12-04 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for donepezil and Cortical Lewy Body Disease
| Article | Year |
|---|---|
[Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cholinesterase Inhibitors; Cognitive Dysfuncti | 2014 |
Exploring the role of donepezil in dementia with Lewy bodies.
Topics: Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Humans; Indans; Lewy Body Disease; P | 2015 |
Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Lewy Body Disease; Piperidi | 2016 |
Diagnosis and treatment of dementia with Lewy bodies.
Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agen | 2008 |
Reports in pharmacological treatments in geriatric psychiatry: is there anything new or just adding to old evidence?
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Therapy; Evidence-Base | 2008 |
[Clinical and pathological findings in dementia with Lewy bodies].
Topics: Aged; Atrophy; Brain; Cholinesterase Inhibitors; Diagnosis, Differential; Diagnostic Imaging; Donepe | 2008 |
Issues facing home-based medical support services.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Caregivers; Delirium; Dementia; Diagnosis, Differenti | 2010 |
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.
Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; | 2010 |
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Topics: Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Humans; Indans; Lewy Body Disea | 2012 |
[Diffuse Lewy body disease].
Topics: Cholinesterase Inhibitors; Donepezil; History, 20th Century; Humans; Indans; Lewy Body Disease; Pipe | 2003 |
[Dementia with Lewy bodies].
Topics: Aged; Antipsychotic Agents; Brain; Cholinesterase Inhibitors; Diagnostic Imaging; Donepezil; Dopamin | 2003 |
The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
Topics: Aged; Basal Ganglia Diseases; Behavior; Cholinesterase Inhibitors; Clinical Trials as Topic; Cogniti | 2004 |
[Community strategies for rehabilitation in senile dementia].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Community Mental Health Services; Diagnosis, Differentia | 2005 |
Current and emerging pharmacological treatment options for dementia.
Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Human | 2006 |
[Medical treatment of Alzheimer's disease].
Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; | 2006 |
[Acetylcholinesterase inhibitors for dementia--an update].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia; Donepezil; Galanta | 2007 |
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Donepezil; Evidence-Base | 2008 |
Successful treatment of behavioural problems in dementia using a cholinesterase inhibitor: the ethical questions.
Topics: Aged; Aged, 80 and over; Australia; Cholinesterase Inhibitors; Donepezil; Ethics; Hallucinations; Hu | 2002 |
13 trials available for donepezil and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study.
Topics: Aged; Aged, 80 and over; Data Interpretation, Statistical; Disease Progression; Donepezil; Double-Bl | 2013 |
Effects of Donepezil on Extrapyramidal Symptoms in Patients with Dementia with Lewy Bodies: A Secondary Pooled Analysis of Two Randomized-Controlled and Two Open-Label Long-Term Extension Studies.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Datasets as Topic; Disease Progression; Donepezi | 2015 |
Adequacy of Using Consensus Guidelines for Diagnosis of Dementia with Lewy Bodies in Clinical Trials for Drug Development.
Topics: Aged; Aged, 80 and over; Consensus; Dementia; Donepezil; Female; Guideline Adherence; Humans; Indans | 2016 |
Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: An exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Cognition; Cytochrome P-450 CYP2D6; Donepezil; | 2016 |
Pretreatment Cognitive Profile Likely to Benefit from Donepezil Treatment in Dementia with Lewy Bodies: Pooled Analyses of Two Randomized Controlled Trials.
Topics: Aged; Cognition; Donepezil; Drug Monitoring; Female; Humans; Indans; Lewy Body Disease; Male; Mental | 2016 |
Improved visual hallucination by donepezil and occipital glucose metabolism in dementia with Lewy bodies: the Osaki-Tajiri project.
Topics: Aged, 80 and over; Donepezil; Female; Glucose; Hallucinations; Humans; Image Interpretation, Compute | 2010 |
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cognition; Donepezil; Double-Blind Method; Femal | 2012 |
What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Topics: Cholinesterase Inhibitors; Dementia; Donepezil; Drug Administration Schedule; Humans; Indans; Lewy B | 2003 |
Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Donepezil; Feasibility Studies; Female; Humans; | 2006 |
Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?
Topics: Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Humans; Indans; Lewy Body Di | 2006 |
Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Attention; Chi-Square Distribution; Cholinesterase Inhibitors; Cognition; D | 2007 |
Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Antiparkinson Agents; Antips | 2007 |
Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Electromyography | 2000 |
38 other studies available for donepezil and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.
Topics: Aged; Bradycardia; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Humans; Indans; Lewy Body | 2014 |
The Relationship Between Medial Temporal Lobe Atrophy and Cognitive Impairment in Patients With Dementia With Lewy Bodies.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amygdala; Atrophy; Cognition Disorders; Do | 2015 |
Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Behavior; Behavioral Symptoms; Cholinesterase Inhibitors; Cognition; Dement | 2016 |
DatSCAN In Differential Diagnostics of Lewy Body Disease.
Topics: Aged, 80 and over; Alzheimer Disease; Czech Republic; Diagnosis, Differential; Donepezil; Female; Hu | 2016 |
Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy.
Topics: Actigraphy; Aged; Aged, 80 and over; Delusions; Donepezil; Dose-Response Relationship, Drug; Drug Ad | 2017 |
[Case of dementia with Lewy bodies showing cervical dystonia after donepezil administration].
Topics: Aged; Donepezil; Electromyography; Female; Humans; Indans; Lewy Body Disease; Piperidines; Torticoll | 2010 |
Efficacy of low-dose donepezil for visual hallucinations in a patient with dementia with Lewy bodies.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Female; Hallucinations | 2010 |
A case of dementia with Lewy bodies that temporarily showed symptoms similar to Creutzfeldt-Jakob disease.
Topics: Aged; Brain Ischemia; Cholinesterase Inhibitors; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential | 2010 |
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions: Evidence is not satisfactory.
Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; | 2011 |
Pisa syndrome caused by an acetylcholinesterase inhibitor in a patient with dementia with Lewy bodies.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Dyskinesia, Drug-Induced; Female; Humans; Indans; Lewy B | 2011 |
[Why choose another cholinesterase inhibitor than donepezil?].
Topics: Cholinesterase Inhibitors; Conflict of Interest; Donepezil; Drug Costs; Humans; Indans; Lewy Body Di | 2012 |
Application of the VSRAD, a specific and sensitive voxel-based morphometry, to comparison of entorhinal cortex atrophy between dementia with Lewy bodies and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Data Interpretation, Statistical; Donepezil; En | 2012 |
Donepezil-induced sleep spindle in a patient with dementia with Lewy bodies: a case report.
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Humans; Indans; Lewy Bod | 2012 |
Severe worsening of parkinsonism in Lewy body dementia due to donepezil.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Disease; Piperidines | 2003 |
Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Brain; Carbamates; Cholinesterase Inhibitors; Diagnos | 2004 |
Two cases of quetiapine augmentation for donepezil-refractory visual hallucinations in dementia with Lewy bodies.
Topics: Aged; Antipsychotic Agents; Dibenzothiazepines; Donepezil; Drug Resistance; Drug Synergism; Drug The | 2003 |
Neuroleptic malignant syndrome induced by donepezil.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Disease; Neuroleptic M | 2004 |
Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Benzodiazepines; Cholinesterase Inhibitors; Clonazepam; Do | 2003 |
A case study in the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galant | 2004 |
Severe worsening of parkinsonism in Lewy body dementia due to donepezil.
Topics: Acetylcholine; Aged; Basal Ganglia; Cholinesterase Inhibitors; Disease Progression; Donepezil; Dopam | 2004 |
[A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: a case report].
Topics: Aged; Catatonia; Donepezil; Female; Hallucinations; Humans; Indans; Lewy Body Disease; Nootropic Age | 2004 |
Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Disease; Neuroprotecti | 2005 |
Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies.
Topics: Aged; Cholinesterase Inhibitors; Consciousness Disorders; Donepezil; Female; Hallucinations; Hemodyn | 2005 |
Quantitative electroencephalogram analysis in dementia with Lewy bodies and Alzheimer's disease.
Topics: Aged; Algorithms; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Electroencephalography; F | 2005 |
A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
Topics: Age Factors; Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Female; Humans; Indans; Lewy Body | 2005 |
Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
Topics: Aged; Cholinesterase Inhibitors; Disease Progression; Donepezil; Galantamine; Humans; Indans; Lewy B | 2005 |
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Double-Blind Metho | 2006 |
Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB.
Topics: Aged; Aged, 80 and over; Cerebrovascular Circulation; Donepezil; Female; Hallucinations; Humans; Ind | 2006 |
Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.
Topics: Aged; Analysis of Variance; Cholinesterase Inhibitors; Clinical Trials as Topic; Data Interpretation | 2007 |
[Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor].
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Hallucinations; Humans; Indans; Lewy Body Disease; Male; | 2007 |
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Autopsy; Cerebral Cortex; Cholinesterase Inhibitors; | 2007 |
Donepezil for the treatment of psychosis in dementia with Lewy bodies.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Disease; Male; Piperid | 2000 |
Donepezil for behavioural disorders associated with Lewy bodies: a case series.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Dis | 2000 |
Charles Bonnet syndrome and dementia.
Topics: Aged; Diagnosis, Differential; Donepezil; Female; Hallucinations; Humans; Indans; Lewy Body Disease; | 2000 |
Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil.
Topics: Aged; Cholinesterase Inhibitors; Circadian Rhythm; Donepezil; Humans; Indans; Lewy Body Disease; Mal | 2000 |
Successful use of donepezil for the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Dis | 2001 |
[Malignant syndrome caused by a combination of bromperidol and donepezil hydrochloride in a patient with probable dementia with Lewy bodies].
Topics: Aged; Donepezil; Drug Therapy, Combination; Hallucinations; Haloperidol; Humans; Indans; Lewy Body D | 2001 |
[A patient with probable dementia with Lewy bodies, who showed improvement of dementia and parkinsonism by the administratim of donepezil].
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Electroencephalography; Humans; Indans; Lewy Body Diseas | 2001 |